Berkeley-based polySpectra is bringing innovation to the medical and dental industry with its first biocompatible 3D resin, COR Bio. Founder and CEO, Raymond Weitekamp, discusses their new product and its distinct advantages.
Topics include:
- COR Bio capabilities in healthcare devices and consumer applications.
- End-use production for medical device components, dental products, and surgical tools.
- COR Bio’s resistance to moisture absorption and not posing a risk of leaching toxins into the body.
related /
RAPID + TCT 2023 Booth Interview: Wohlers Market Report
RAPID + TCT 2023 Booth Interview: DiveDesign
RAPID + TCT 2023 Booth Interview: Digital Supply Chain at Würth
